← Search

Omics · study · 2026

Gene Expression Profiling in Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines Treated with Selinexor

Listed in NCBI GEO

This study focuses on the transcriptional response of diffuse large B-cell lymphoma (DLBCL) cell lines, SU-DHL6 and OCI-LY3, to Selinexor treatment.

Description

Selinexor, a selective inhibitor of nuclear export (SINE), is known for its antitumor properties. RNA-sequencing was performed to investigate gene expression changes in these DLBCL models after 24 and 48 hours of treatment.

The goal is to uncover key molecular pathways and targets influenced by Selinexor, providing insights into its therapeutic potential in DLBCL.

Links

Topics

From keywords
Life Sciences
Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE28338814 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title